New managing director for Boehringer Ingelheim UK
January 13, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim, krumins
Zinta Krumins has been appointed as the managing director of Boehringer Ingelheim UK & Ireland. The appointment will present a …
NICE: Daily Mail ‘misled’ readers
January 13, 2014Sales and Marketing Dillon, NHS, NICE, mail
UK drugs watchdog NICE has hit back at an article in the Daily Mail headlined “Champagne perks of NHS drug …
Sanofi pays $700m to expand rare disease portfolio
January 13, 2014Research and Development, Sales and Marketing Alnylam, Sanofi, rare sidease
Sanofi and Alnylam have announced the expansion of their 2012 agreement to develop and sell treatments for rare genetic diseases. …
Thought leader mapping: do we need a radical rethink?
January 13, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Havas, bartley, marketing, sales, thought leader
The effectiveness of healthcare communications is often more reliant on who’s delivering the message than the content of the message …
New chief executive for Quanta Fluid Solutions
January 13, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing milad, quanta
Medical devices firm Quanta Fluid Solutions has announced the appointment of John Milad as chief executive. Milad’s career spans 20 …
Treat patients ‘more holistically’
January 13, 2014Sales and Marketing Hunt, Mid Staffs, NHS, new year
UK health secretary Jeremy Hunt has spoken of the challenges faced by the NHS in a New Year message to …
FDA approves Farxiga
January 10, 2014Sales and Marketing AstraZeneca, BMS, FDA, Forxiga, diabetes
The FDA has approved Farxiga, the diabetes treatment developed by AstraZeneca and Bristol-Myers Squibb as part of their soon-to-be-defunct diabetes …
Chris Kilbee appointed Group director of UBM Pharma Portfolio


January 10, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CPhI, UBM pharma, amsterdam
Amsterdam: CPhI, part of UBM Live, has announced the appointment of Chris Kilbee to the role of Group director of …
UK cancer death rate could be halved by 2030
January 10, 2014Research and Development, Sales and Marketing Cancer, Taylor, UCL, wardle
British cancer deaths could drop 50% by 2030 if early diagnosis and improved treatment policies are put in place academics …
World’s first Alzheimer’s vaccine trial begins
January 10, 2014Research and Development, Sales and Marketing AC Immune, ACI-35, Alzheimer's, Vaccine
AC Immune, a privately-held biotech based in Switzerland, has launched the world’s first trial of a vaccine against a protein …
Merck Serono hires global chief medical officer
January 10, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck Serono, hildemann
Merck Serono has appointed Steven Hildemann as global chief medical officer and head of its global Medical and Safety unit. …
Novartis faces Japan probe
January 10, 2014Sales and Marketing Diovan, Japan, Novartis
Novartis is under pressure in Japan where authorities are looking at the way the Swiss firm promoted its blood pressure …
PM Society Advertising awards finalists announced
January 9, 2014Medical Communications, Sales and Marketing London, advertising, pm awards
The finalists for the 2013 PM Society Advertising awards have been announced today as pharma and their med comms agencies …
Teva names new chief executive
January 9, 2014Manufacturing and Production, Research and Development, Sales and Marketing Levin, Teva, erez vigodman, generics
The world’s biggest generic drugmaker Teva has appointed the chief executive of the world’s biggest generic agrochemical company. Vigodman joins …
EMA to review daclatasvir
January 9, 2014Sales and Marketing BMS, EMA, daclatasvir, hep C
European regulators are to conduct a speedy investigation into one of Bristol-Myers Squibb’s investigational drugs for chronic hepatitis C virus …
Forest to buy Aptalis for $2.9 billion
January 9, 2014Sales and Marketing Forest, aptlias, canasa, maris
Forest Laboratories will spend around $2.9 billion to purchase Aptalis, a privately-held US firm specialising in treatments for gastrointestinal disorders …
Just:: hires managing director
January 9, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Just::, PR, comms
PR firm Just:: Health Communications has hired Kirsty Mearns as a managing director to lead its senior management team. She …
Cancer treatment Abraxane gets EU nod
January 9, 2014Sales and Marketing Abraxane, Cancer, Celgene, EU, pancreatic
Celgene’s cancer drug Abraxane has been approved by European regulators to treat patients with metastatic adenocarcinoma of the pancreas, or …
Imbruvica boost for Pharmacyclics
January 8, 2014Sales and Marketing Janssen, Pharmacyclics, imbruvica
Pharmacyclics and Janssen Biotech have received a huge boost as a late-stage trial of their first-in-class, oral blood cancer drug …
AstraZeneca strikes cancer vaccine pact
January 8, 2014Research and Development, Sales and Marketing AstraZeneca, Cancer, MedImmune, oncology
AstraZeneca’s biologics arm MedImmune has struck an oncology research deal with UK biotech company Immunocore. The deal, which could be …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
